Michael S. Baum
University College London · 512 works · 20,959 citations · h-index 64
Top works
- Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
- EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCER
- Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.
- Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.
- Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
- Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer.
- Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer.
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- Overview of Randomized Trials of Postoperative Adjuvant Radiotherapy in Breast Cancer
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.
- Organization of Clinical Trial on National Scale: Management of Early Cancer of the Breast
- First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial
- Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
- TAMOXIFEN AND CONTRALATERAL BREAST CANCER
- Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial
- A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast.
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.